Literature DB >> 16183280

A synthesis of 3-deoxydihydrolycoricidine: refinement of a structurally minimum pancratistatin pharmacophore.

James McNulty1, Vladimir Larichev, Siyaram Pandey.   

Abstract

The synthesis of 3-deoxydihydrolycoricidine, a key element toward elucidation of the pancratistatin anticancer pharmacophore, is described. Biological evaluation of this compound showed it to be significantly less active against tumor cells than pancratistatin. In addition to those features previously identified, the requirement of a 2,3,4-triol functionalized ring-C is now definitely established as the minimum pharmacophoric element for potent anticancer activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16183280     DOI: 10.1016/j.bmcl.2005.08.024

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  17 in total

1.  Chemoenzymatic synthesis of Amaryllidaceae constituents and biological evaluation of their C-1 analogues. The next generation synthesis of 7-deoxypancratistatin and trans-dihydrolycoricidine.

Authors:  Jonathan Collins; Uwe Rinner; Michael Moser; Tomas Hudlicky; Ion Ghiviriga; Anntherese E Romero; Alexander Kornienko; Dennis Ma; Carly Griffin; Siyaram Pandey
Journal:  J Org Chem       Date:  2010-05-07       Impact factor: 4.354

2.  A novel synthetic C-1 analogue of 7-deoxypancratistatin induces apoptosis in p53 positive and negative human colorectal cancer cells by targeting the mitochondria: enhancement of activity by tamoxifen.

Authors:  Dennis Ma; Phillip Tremblay; Kevinjeet Mahngar; Pardis Akbari-Asl; Jonathan Collins; Tomas Hudlicky; James McNulty; Siyaram Pandey
Journal:  Invest New Drugs       Date:  2011-04-15       Impact factor: 3.850

3.  Synthesis of C-1 homologues of pancratistatin and their preliminary biological evaluation.

Authors:  Sergey Vshyvenko; Jon Scattolon; Tomas Hudlicky; Anntherese E Romero; Alexander Kornienko
Journal:  Bioorg Med Chem Lett       Date:  2011-06-22       Impact factor: 2.823

Review 4.  Chemistry, biology, and medicinal potential of narciclasine and its congeners.

Authors:  Alexander Kornienko; Antonio Evidente
Journal:  Chem Rev       Date:  2008-05-20       Impact factor: 60.622

5.  Unnatural C-1 homologues of pancratistatin - Synthesis and promising biological activities.

Authors:  Sergey Vshyvenko; Jon Scattolon; Tomas Hudlicky; Anntherese E Romero; Alexander Kornienko; Dennis Ma; Ian Tuffley; Siyaram Pandey
Journal:  Can J Chem       Date:  2012-09-19       Impact factor: 1.118

6.  TOTAL SYNTHESES OF PANCRATISTATIN. A REVIEW.

Authors:  Madhuri Manpadi; Alexander Kornienko
Journal:  Org Prep Proced Int       Date:  2009-02-18       Impact factor: 1.628

7.  Synthesis and biological evaluation of unnatural derivatives of narciclasine: 7-aza-nornarciclasine and its N-oxide.

Authors:  Sergey Vshyvenko; Mary Rose Reisenauer; Snezna Rogelj; Tomas Hudlicky
Journal:  Bioorg Med Chem Lett       Date:  2014-07-19       Impact factor: 2.823

8.  Amaryllidaceae isocarbostyril alkaloids and their derivatives as promising antitumor agents.

Authors:  Laurent Ingrassia; Florence Lefranc; Véronique Mathieu; Francis Darro; Robert Kiss
Journal:  Transl Oncol       Date:  2008-03       Impact factor: 4.243

9.  Synthesis of structurally simplified analogues of pancratistatin: truncation of the cyclitol ring.

Authors:  Madhuri Manpadi; Artem S Kireev; Igor V Magedov; Jeff Altig; Paul Tongwa; Mikhail Yu Antipin; Antonio Evidente; Willem A L van Otterlo; Alexander Kornienko
Journal:  J Org Chem       Date:  2009-09-18       Impact factor: 4.354

10.  Synthesis and biological evaluation of 10-benzyloxy-Narciclasine.

Authors:  Vincenzo Ticli; Zhenze Zhao; Liqin Du; Alexander Kornienko; Tomas Hudlicky
Journal:  Tetrahedron       Date:  2021-10-18       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.